Danaher Corp. (DHR) Social Stream
Featured Post From StockTwits About DHR
$DHR New Press Release:WebChronicleToday, published July 27, 2021
Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions
An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher (NYSE: DHR) Corporation, will expand manufacturing capacity and services across geographies for global life sciences customers. The investment, already underway, includes new sites, expansion at existing factories, and is additional to previously announced investments. It follows five acquisitions made by the companies so far this year. Emmanuel Ligner, Danaher Group Executive, says: "Our customers tell us the (...)
What Else are DHR Traders Talking About?
Other Notable StockTweets About DHR
$DHR on the move up 📈
currently up 3%
other big movers to consider today $MSFT $AAPL $MCD $SHOP
check out the stocks and more on our site-https://assetdash.com
Thu Jul 15th
Today's WORST performing sector just after the open:
Health Care -0.9%
biggest 20 Health Care stocks by mkt cap:
1) $NVO: +0.6%
2) $TMO: +0.0%
3) $DHR: +0.0%
4) $PFE: -0.1%
5) $MRK: -0.2%
see all 20 here:
$DHR $ACN $AVGO $BHP
Why Buy venar?
Competitive Strengths：Leading bespoke central processing algorithm service provider in China enjoying first-mover advantages and rapid revenue growth.VIYI ranks as one of the top five Chinese companies for central processing algorithm services. According to the CIC Report, as of 2020, VIYI has captured 5% of the market share for central processing algorithm services provided to internet advertisement and online gaming acceleration industries.
VIYI is ideally positioned to grow its revenue quickly as a leading central processing algorithm service provider in China. According to the CIC Report, VIYI is the only company amongst its competitors to provide central processing algorithm service solutions in both internet advertisement and online game acceleration industries.